Life After AREDS 2: What Should We Recommend to Patients With or at Risk of Amd?

Publication Date: 
Wednesday, November 12, 2014
Category: 
Author: 
Langis Michaud
Julie Brûlé
Jean-Sebastien Dufour
Pierre Forcier
Guillaume Fortin
Kevin Messier
Marc-André Rhéaume
Yvon Rhéaume
Patrick Simard
Christina Clark
Volume: 
76
Number: 
1
To establish a consensus on clinical recommendation of oral supplementation for patients with or at risk of developing age-related macular degeneration (AMD), from the perspective of the Age-Related Eye Disease Study 2 (AREDS 2) and other studies.